The agency remains concerned about the safety of human food products (e.g. meat, milk, and eggs) from animals that consume CBD, as there is a lack of data establishing safe CBD residue levels. Based on the lack of scientific information supporting the safety of CBD in food, the FDA is also indicating today that it cannot conclude that CBD is generally recognized as safe (GRAS) among qualified experts for its use in human or animal food. Other violations include marketing Yuppie CBD products as dietary supplements and adding CBD to human and animal foods. "As we work quickly to further clarify our regulatory approach for products containing cannabis and cannabis-derived compounds like CBD, we’ll continue to monitor the marketplace and take action as needed against companies that violate the law in ways that raise a variety of public health concerns. Moreover, the FDA has not approved any products containing cannabis-derived compounds or cannabis for medical purposes. Today, the U.S. Food and Drug Administration issued warning letters to 15 companies for illegally selling products containing cannabidiol (CBD) in ways that violate the Federal Food, Drug, and Cosmetic Act (FD&C Act).

Representations regarding the efficacy and safety of Indigo Ridge Hemp products have not been evaluated by the Food and Drug Administration. In line with our mission to protect the public, foster innovation, and promote consumer confidence, this overarching approach regarding CBD is the same as the FDA would take for any other substance that we regulate," said FDA Principal Deputy Commissioner Amy Abernethy, M.D., Ph.D. So follow the these golden rules; set goals, keep yourself happy, don't take stress and keep your health intact. It may take a little trial and error. Hemp, the plant normally used to create CBD products, contains little to no THC. That means you can get a lot of CBD from relatively little product. It’s important to note that while oil can be extracted from hemp seeds, this oil, known as hemp seed oil, does not contain any cannabinoids, including CBD. CBD is marketed in a variety of product types, such as oil drops, capsules, syrups, food products such as chocolate bars and teas, and topical lotions and creams.

The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products. Department of Health and Human Services, promotes and protects the public health by, among other things, assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. Plus, wider acceptance and use of CBD products makes it more likely that CBD oils, and other CBD preparations, will maintain their current legal status. The FDA has requested responses from the companies within 15 working days stating how the companies will correct the violations. The FDA has previously sent warning letters to other companies illegally selling CBD products in interstate commerce that claimed to prevent, diagnose, mitigate, treat or cure serious diseases, such as cancer, or otherwise violated the FD&C Act. We didn’t return the product because it actually made the pain easier to manage, but it’s good to see that a company is so confident about its own products. The company designed new packaging for goods on Amazon different from what it uses on its own website. The company is an FDA Registered Entity, a Utah Registered Processor and Manufacturer, a Utah Department of Agriculture Approved Food Facility, an HIA Member, an NCIA Member.

In addition, the FDA is not aware of any basis to conclude that CBD is GRAS among qualified experts for its use in human or animal food. Under the FD&C Act, it is illegal to introduce into interstate commerce any human or animal food to which certain drug ingredients, such as CBD, have been added. As outlined in the warning letters issued today, these particular companies are using product webpages, online stores and social media to market CBD products in interstate commerce in ways that violate the FD&C Act, including marketing CBD products to treat diseases or for other therapeutic uses for humans and/or animals. Unlike drugs approved by the FDA, there has been no FDA evaluation of whether these unapproved products are effective for their intended use, what the proper dosage might be, how they could interact with FDA-approved drugs, or whether they have dangerous side effects or other safety concerns.